Differential responses of CD45+ve T-cell subsets to MBP in multiple sclerosis

M Ponsford1, G Mazza, J Coad

  • 1Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, Bristol, UK. M.Ponsford@bristol.ac.uk

Insights

Multiple sclerosis (MS) patients show a reduced response to purified protein derivative (PPD) but a distinct memory response to myelin basic protein (MBP), particularly in CD45RO+ T-cells, indicating prior T-cell activation in MS.

Area of Science:

  • Immunology
  • Neuroimmunology
  • T-cell immunology

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
  • The role of T-cell responses to myelin antigens in MS pathogenesis is crucial but not fully understood.
  • Understanding T-cell kinetics and memory responses is key to developing targeted therapies.

Purpose of the Study:

  • To compare the proliferative responses of T-cells from MS patients and healthy individuals to purified protein derivative (PPD) and myelin basic protein (MBP).
  • To investigate the kinetic profiles and subset-specific responses (CD45RO+ and CD45RA+ T-cells) to these antigens.
  • To determine if a measurable memory response to MBP exists in MS patients.

Main Methods:

  • Peripheral blood mononuclear cells (PBMCs) from 20 healthy individuals and 28 MS patients were cultured.
  • Proliferative responses to PPD and MBP were monitored over 10 days using kinetic assays.
  • T-cell subsets (CD45RO+ and CD45RA+) were enriched to analyze subset-specific responses.

Main Results:

  • MS patients showed a significantly reduced secondary response to PPD compared to controls.
  • Responses to MBP did not differ in magnitude or pattern between MS patients and controls in whole PBMC populations.
  • Enriched CD45RO+ T-cells from MS patients exhibited a heightened response to MBP on day 4, suggesting a more active role and memory response in MS.

Conclusions:

  • A measurable memory response to MBP exists in MS patients, implying prior in vivo activation of MBP-reactive T lymphocytes.
  • The CD45RO+ T-cell subset plays a more active role in the MBP response in MS patients.
  • These findings contribute to understanding T-cell dynamics in MS and suggest potential therapeutic targets.